Autopsy report · NCT05661435

Utility of Remote Lung Auscultation in Transitions of Care After Pulmonary Exacerbations of COPD

“Sponsor Hold”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Sponsor

Strados Labs, Inc.

Sponsor type

Industry

Conditions

Chronic Obstructive Pulmonary Disease (COPD)

Interventions

RESP Biosensor

Participants

0

Sites

2

Countries

United States

Trials that died the same way

• Safety, PD & Efficacy of MT-3724 for the Treatment of Patients With Relapsed or Refractory DLBCL
  “Sponsor decision following clinical hold” (79% match in meaning)
• An Efficacy and Safety Study of Cisapride for Improving Symptoms Associated With Gastroparesis in Patients With Diabetes Mellitus
  “Sponsor request” (76% match in meaning)
• Cymbalta for Fibromyalgia Pain - Predictive Value of Small Fiber Changed
  “Sponsor related” (75% match in meaning)
• Phase 3 Study to Assess the Efficacy and Safety of Batoclimab as Induction and Maintenance Therapy in Adult Participants With Generalized Myasthenia Gravis
  “Sponsor Decision” (74% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.